Æterna Zentaris Marge brute
Quel est le Marge brute de Æterna Zentaris?
Le Marge brute de Æterna Zentaris, Inc. est 95.11%
Quelle est la définition de Marge brute?
La marge brute est la différence entre le revenu et le coût des biens vendus, divisée par le revenu et exprimée en pourcentage.
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
Marge brute des entreprises dans Health Care secteur sur TSX par rapport à Æterna Zentaris
Que fait Æterna Zentaris?
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen brand name. Aeterna Zentaris Inc. has a license agreement with University Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercialization of the treatment for neuromyelitis optica spectrum disorder; and to develop human 3D intestinal tissue models to study infection biology; and for pre-clinical development towards the potential treatment of Parkinson's disease. It also has a license agreement with Consilient Health Ltd., Novo Nordisk Novo Nordisk Health Care AG, and NK MEDITECH Ltd. for the development and commercialization of macimorelin in the United States and Canada, as well as The University of Sheffield, the United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.
Entreprises avec marge brute similaire à Æterna Zentaris
- Credit Suisse AG a Marge brute de 95.06%
- ADVFN Plc a Marge brute de 95.06%
- Nippon Active Value Fund plc a Marge brute de 95.07%
- Automatic Bank Services a Marge brute de 95.07%
- Bank of Tianjin Co a Marge brute de 95.08%
- Borussia Dortmund GmbH & Co. KGaA a Marge brute de 95.09%
- Æterna Zentaris a Marge brute de 95.11%
- TMX a Marge brute de 95.12%
- DCM a Marge brute de 95.13%
- Eagle Eye Solutions plc a Marge brute de 95.15%
- Smithson Investment Trust PLC a Marge brute de 95.16%
- JPMorgan Global Emerging Markets Income Trust Plc a Marge brute de 95.16%
- Bank Of Nova Scotia a Marge brute de 95.17%